NCT00013598View on ClinicalTrials.gov

Treatment of Nonalcoholic Steatohepatitis With Pioglitazone

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2001

Study Completion Date

March 31, 2004

Conditions
Fatty LiverNonalcoholic Steatohepatitis
Interventions
DRUG

Pioglitazone

Trial Locations (1)

20892

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00013598 - Treatment of Nonalcoholic Steatohepatitis With Pioglitazone | Biotech Hunter | Biotech Hunter